Skip to main content

Organigram Global Inc(OGI-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.4250
Day High1.4900
Open:1.4600
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Organigram Global Inc

Select a category then submit the form to load news
Tipranks
Organigram Extends SHRED Brand Into Fast-Acting Shot-Sized Cannabis Beverages
Business Wire
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
Tipranks
Organigram Global Moves to Acquire Germany’s Sanity Group in Financed Deal with BAT Support
Tipranks
Organigram Expands Global Footprint With New Medical Cannabis Products in Australia
Business Wire
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
Tipranks
Organigram Global Moves to Acquire Stake in Germany’s Sanity Group, Expanding European Cannabis Reach
Tipranks
Analysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and Spyre Therapeutics (SYRE)
Tipranks
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI), Taysha Gene Therapies (TSHA) and BioRestorative Therapies (BRTX)
Tipranks
Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal
Tipranks
Analysts Offer Insights on Healthcare Companies: OrganiGram Holdings (OGI) and Qiagen (QGEN)
Tipranks
Alliance Global Partners Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)
Tipranks
Organigram to Acquire Germany’s Sanity Group in Major European Cannabis Push
Business Wire
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
Business Wire
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company
Tipranks
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Quest Diagnostics (DGX) and OrganiGram Holdings (OGI)
Tipranks
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and OrganiGram Holdings (OGI)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (ZBH) and OrganiGram Holdings (OGI)
Tipranks
Organigram Delivers Strong Q1 2026 Growth and Expands U.S. Reach
Business Wire
Organigram Reports First Quarter Fiscal 2026 Results
Tipranks
Organigram Sets February 10 Date to Release Q1 2026 Results
Business Wire
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026
Tipranks
OrganiGram Sets March 30, 2026 Date for Annual and Special Shareholder Meeting
Tipranks
Organigram Deepens Phylos Partnership to Secure Long-Term Cannabis Genetics Edge
Business Wire
Organigram Extends Innovation Investment with Phylos
Tipranks
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and OrganiGram Holdings (OGI)
Tipranks
Organigram Achieves Record Financial Results and Expands Market Leadership
Business Wire
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results
Tipranks
Organigram to Announce Q4 2025 Earnings on December 16
Tipranks
Organigram Appoints New CEO to Drive Global Growth
Business Wire
Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025
Tipranks
Organigram Holdings Appoints New CEO to Drive Global Expansion
Tipranks
Canadians Call for Modernized Cannabis Policies to Boost Economy

Profile

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.